These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10230509)
1. Studies on the synthesis and in vitro antitumor activity of the isoquinolone derivatives. Cheon SH; Lee JY; Chung BH; Choi BG; Cho WJ; Kim TS Arch Pharm Res; 1999 Apr; 22(2):179-83. PubMed ID: 10230509 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent. Cheon SH; Park JS; Chung BH; Choi BG; Cho WJ; Choi SU; Lee CO Arch Pharm Res; 1998 Apr; 21(2):193-7. PubMed ID: 9875430 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents. Cho WJ; Park MJ; Chung BH; Lee CO Bioorg Med Chem Lett; 1998 Jan; 8(1):41-6. PubMed ID: 9871625 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of isoquinolinone type anticancer agent. Cheon SH; Park JS; Lee JY; Lee YN; Yi H; Chung BH; Choi BG; Cho WJ; Choi SU; Lee CO Arch Pharm Res; 2001 Aug; 24(4):276-80. PubMed ID: 11534756 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship studies of 2,3-dihydroimidazo[2,1-a]isoquinoline analogs as antitumor agents. Cheon SH; Park JS; Jeong SH; Chung BH; Choi BG; Cho WJ; Kang BH; Lee CO Arch Pharm Res; 1997 Apr; 20(2):138-43. PubMed ID: 18975191 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines. Houlihan WJ; Munder PG; Handley DA; Cheon SH; Parrino VA J Med Chem; 1995 Jan; 38(2):234-40. PubMed ID: 7830265 [TBL] [Abstract][Full Text] [Related]
7. Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines. Bermejo A; Andreu I; Suvire F; Léonce S; Caignard DH; Renard P; Pierré A; Enriz RD; Cortes D; Cabedo N J Med Chem; 2002 Nov; 45(23):5058-68. PubMed ID: 12408717 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity evaluation of indolo-, pyrrolo-, and benzofuro-quinolin-2(1H)-ones and 6-anilinoindoloquinoline derivatives. Chen YL; Chung CH; Chen IL; Chen PH; Jeng HY Bioorg Med Chem; 2002 Aug; 10(8):2705-12. PubMed ID: 12057659 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs. Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors. Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658 [TBL] [Abstract][Full Text] [Related]
11. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity. Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187 [TBL] [Abstract][Full Text] [Related]
12. Antineoplastic activity of benzimidazo[1,2-b]-isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles. Weinkauf RL; Chen AY; Yu C; Liu L; Barrows L; LaVoie EJ Bioorg Med Chem; 1994 Aug; 2(8):781-6. PubMed ID: 7894971 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs. Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles). Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series. Tarby CM; Kaltenbach RF; Huynh T; Pudzianowski A; Shen H; Ortega-Nanos M; Sheriff S; Newitt JA; McDonnell PA; Burford N; Fairchild CR; Vaccaro W; Chen Z; Borzilleri RM; Naglich J; Lombardo LJ; Gottardis M; Trainor GL; Roussell DL Bioorg Med Chem Lett; 2006 Apr; 16(8):2095-100. PubMed ID: 16458511 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 3-Methylidene-1-tosyl-2,3-dihydroquinolin-4(1H)-ones as Potent Cytotoxic Agents. Koszuk J; Bartosik T; Wojciechowski J; Wolf WM; Janecka A; Drogosz J; Długosz A; Krajewska U; Mirowski M; Janecki T Chem Biodivers; 2018 Sep; 15(9):e1800242. PubMed ID: 29935105 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C). Koneru PB; Lien EJ; Avramis VI Pharm Res; 1993 Apr; 10(4):515-20. PubMed ID: 8483833 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of some structural modifications of pancratistatin. Rinner U; Hillebrenner HL; Adams DR; Hudlicky T; Pettit GR Bioorg Med Chem Lett; 2004 Jun; 14(11):2911-5. PubMed ID: 15125958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]